NVSEF Stock DD Novartis AG 07/20/2014 23:56:30

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
NVSEF Novartis AG $NVSEF Company Overview

Stock Message Board http://investorshangout.com/search?q=NVSEF&am...mp;yt1=Go!

Last Updated: 07/20/2014 23:56:25

Current Price and Quotes
Last Price 88.998
Previous Close 88.36 Open 89.08
Daily Range N/A - 89.0803 52wk Range 70.92 - 91.68
Volume 801 Dividend N/A
Average Vol (3m) 23,859 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 58,831,000 57,561,000 59,375,000 51,561,000
Cost of Revenue 19,608,000 18,756,000 18,983,000 14,488,000
Gross Profit 39,223,000 38,805,000 40,392,000 37,073,000
Operating Expenses

Research and Development 9,852,000 9,332,000 9,583,000 9,070,000
Sales, General and Admin. 18,461,000 18,280,000 20,029,000 16,477,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 10,910,000 11,193,000 10,780,000 11,526,000
Income From Continuing Operations

Add'l Income/Expense Items (92,000) (96,000) (2,000) 64,000
Earnings Before Interest and Tax 11,418,000 11,649,000 11,306,000 12,394,000
Interest Expense 683,000 724,000 751,000 692,000
Earnings Before Tax 10,735,000 10,925,000 10,555,000 11,702,000
Income Tax 1,443,000 1,542,000 1,483,000 1,733,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary 600,000 552,000 528,000 804,000
Net Income Cont. Operations 9,892,000 9,935,000 9,600,000 10,773,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 9,292,000 9,383,000 9,072,000 9,969,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 9,292,000 9,383,000 9,072,000 9,969,000

Recent News

Jul 17, 2014 Hopp Acquires LTS Shares From Novartis & BWK
Jul 17, 2014 Santhera Repositions Omigapil in Congenital Muscular Dystrophy and Initiates Clinical Development Program with Public-Private Partners
Jul 17, 2014 Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook
Jul 16, 2014 Research and Markets: Global Transdermal Drug Delivery Market 2014-2018 with ANI Pharmaceuticals, Antares Pharma, Bayer, Janssen Pharma & Novartis Dominating
Jul 15, 2014 Banner Alzheimer's Institute Announces Partnership with Novartis in New Study of Alzheimer's Prevention Treatments
Jul 15, 2014 Research and Markets: Global Animal (Companion & Production) Healthcare Market 2014-2019 Featuring Key Companies, Zoetis, Merck, Merial, Bayer and Novartis
Jul 15, 2014 Novartis to license Google "smart lens" technology
Jul 15, 2014 Novartis announces collaboration with Banner Alzheimer's Institute on a pioneering prevention study for Alzheimer's Disease
Jul 11, 2014 Research and Markets: Global Alzheimer's Drugs Market 2014-2018 with Eisai Co. Forest Laboratories, Janssen Pharmaceuticals & Novartis Dominating
Jul 10, 2014 Microbix Sues Novartis for Infringement of its VIRUSMAX® Patent In Europe

1
2
3
4
5
6
7
8
next >
last >>

NVSEF Novartis AG Research DD Guide

Stock Message Board http://investorshangout.com/search?q=NVSEF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/NVSEF/quote
Stock Chart http://www.otcmarkets.com/stock/NVSEF/chart
Company Info http://www.otcmarkets.com/stock/NVSEF/company-info
Recent News http://www.otcmarkets.com/stock/NVSEF/news
Financials http://www.otcmarkets.com/stock/NVSEF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/NVSEF/filings
Short Sales http://www.otcmarkets.com/stock/NVSEF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/NVSEF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/NVSEF/research
Summary http://finance.yahoo.com/q?s=NVSEF
Historical Prices http://finance.yahoo.com/q/hp?s=NVSEF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=NVSEF
Basic Chart http://finance.yahoo.com/q/bc?s=NVSEF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=NVSEF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=NVSEF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=NVSEF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=NVSEF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=NVSEF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=NVSEF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=NVSEF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=NVSEF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=NVSEF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=NVSEF
Balance Sheet http://finance.yahoo.com/q/bs?s=NVSEF
Cash Flow http://finance.yahoo.com/q/cf?s=NVSEF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/NVSEF
Market Watch http://www.marketwatch.com/investing/stock/NVSEF
Bloomberg http://www.bloomberg.com/quote/NVSEF:US
Morningstar http://quotes.morningstar.com/stock/s?t=NVSEF
Bussinessweek http://investing.businessweek.com/research/st...cker=NVSEF
Barchart http://www.barchart.com/quotes/stocks/NVSEF
OTC Short Report http://otcshortreport.com/index.php?index=NVSEF
Investopedia http://www.investopedia.com/markets/stocks/NVSEF/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Knee Treatment with Overture's Latest System

Updated Category News Views 312

Full Commercial Launch of the OvertureTi Knee Resurfacing System Overture Orthopaedics is making headlines as it proudly announces the full commercial launch of its advanced OvertureTi Knee Resurfacing System. This medical device targets early osteoarthritis and cartilage defects effectively, presenting a breakthrough for patients seeking alternatives to traditional joint...

Continue Reading
Elis SA: Key Insights on Recent Share Buyback Activities

Updated Category News Views 130

Elis SA's Recent Share Buyback Activities Elis SA has made a mark with its recent trading activities associated with its own shares, particularly highlighting a series of transactions carried out during a specified period. Overview of the Buyback Program As part of its strategic financial planning, Elis has engaged in a buyback program that has garnered attention. The...

Continue Reading
Kevin O'Leary's Essential Advice for Startups on Content Investment

Updated Category News Views 262

O'Leary: Tools Are Cheap, But Talent Isn't Entrepreneur and "Shark Tank" star Kevin O'Leary emphasizes a critical insight for startups: while the cost of creating digital content has drastically reduced, the true value comes from the talent that produces it. O'Leary shared his thoughts in a recent video, indicating that although the cost of technology has significantly...

Continue Reading
The St. James Reinvents Lacrosse with Spencer Ford at the Helm

Updated Category News Views 237

The St. James Strengthens Lacrosse Initiatives In an exciting development, The St. James has appointed Spencer Ford as the new Director of Lacrosse, ushering in a transformative approach to lacrosse for both boys and girls. With a vast wealth of experience spanning nearly twenty years, Ford is not only a seasoned professional player but also an accomplished coach and...

Continue Reading
Hudbay Minerals Celebrates Permit Approval for Copper World

Updated Category News Views 119

Hudbay Minerals Receives Final Permit for Copper World Project Hudbay Minerals Inc. (TSX, NYSE: HBM), a prominent player in the mining industry, has taken a significant step forward by securing the final major permit necessary for its Copper World project in Arizona. This milestone not only enhances the company’s operational capacity but also solidifies its commitment...

Continue Reading